116 related articles for article (PubMed ID: 18845645)
1. 11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia.
Osmond JM; Dorrance AM
Endocrinology; 2009 Feb; 150(2):713-9. PubMed ID: 18845645
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia.
Dorrance AM; Rupp NC; Nogueira EF
Hypertension; 2006 Mar; 47(3):590-5. PubMed ID: 16365191
[TBL] [Abstract][Full Text] [Related]
3. Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart.
Wilson P; Morgan J; Funder JW; Fuller PJ; Young MJ
Clin Sci (Lond); 2009 May; 116(9):731-9. PubMed ID: 18990085
[TBL] [Abstract][Full Text] [Related]
4. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
Young MJ; Moussa L; Dilley R; Funder JW
Endocrinology; 2003 Mar; 144(3):1121-5. PubMed ID: 12586788
[TBL] [Abstract][Full Text] [Related]
5. 11beta-hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation.
Zhang ZH; Kang YM; Yu Y; Wei SG; Schmidt TJ; Johnson AK; Felder RB
Hypertension; 2006 Jul; 48(1):127-33. PubMed ID: 16717146
[TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen therapy on cerebral arteries during stroke in female rats.
Goodrow GJ; Vitullo L; Cipolla MJ
Menopause; 2005; 12(1):99-109. PubMed ID: 15668607
[TBL] [Abstract][Full Text] [Related]
7. Ischemic and hemorrhagic disturbances in cerebral circulation alter contractile responses of the rat middle cerebral artery.
Fadyukova OE; Storozhevykh TP; Pinelis VG; Koshelev VB
Brain Res; 2004 Jan; 995(1):145-9. PubMed ID: 14644480
[TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor increases regional cerebral blood flow and reduces infarct size after experimental ischemia in a rat model.
Tanaka R; Miyasaka Y; Yada K; Ohwada T; Kameya T
Stroke; 1995 Nov; 26(11):2154-8; discussion 2158-9. PubMed ID: 7482665
[TBL] [Abstract][Full Text] [Related]
9. Peripheral administration of carbenoxolone reduces ischemic reperfusion injury in transient model of cerebral ischemia.
Vakili A; Hosseinzadeh SA; Khorasani MZ
J Stroke Cerebrovasc Dis; 2009; 18(2):81-5. PubMed ID: 19251182
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.
Rigsby CS; Pollock DM; Dorrance AM
Microvasc Res; 2007 May; 73(3):198-205. PubMed ID: 17250855
[TBL] [Abstract][Full Text] [Related]
11. Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke.
Deutsch C; Portik-Dobos V; Smith AD; Ergul A; Dorrance AM
Microvasc Res; 2009 Jun; 78(1):100-6. PubMed ID: 19374911
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.
Pires PW; Rogers CT; McClain JL; Garver HS; Fink GD; Dorrance AM
Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H87-97. PubMed ID: 21551278
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
[TBL] [Abstract][Full Text] [Related]
15. Activation of mineralocorticoid receptors by exogenous glucocorticoids and the development of cardiovascular inflammatory responses in adrenalectomized rats.
Young MJ; Morgan J; Brolin K; Fuller PJ; Funder JW
Endocrinology; 2010 Jun; 151(6):2622-8. PubMed ID: 20410198
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.
Pires PW; Girgla SS; Moreno G; McClain JL; Dorrance AM
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H658-69. PubMed ID: 25015967
[TBL] [Abstract][Full Text] [Related]
17. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
18. Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats.
Cipolla MJ; McCall AL; Lessov N; Porter JM
Stroke; 1997 Jan; 28(1):176-80. PubMed ID: 8996508
[TBL] [Abstract][Full Text] [Related]
19. Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study.
Baker CJ; Onesti ST; Solomon RA
J Neurosurg; 1992 Sep; 77(3):438-44. PubMed ID: 1506891
[TBL] [Abstract][Full Text] [Related]
20. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells.
Ge RS; Gao HB; Nacharaju VL; Gunsalus GL; Hardy MP
Endocrinology; 1997 Jun; 138(6):2435-42. PubMed ID: 9165033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
